Crescent Biopharma, Inc.

CBIONASDAQHealthcare● Active

$17.28

$-0.72(-4.00%)

Market Cap$476442432

P/E Ratio—

52W High$27.41

52W Low$8.72

Avg Volume276K

Open$18.27

Beta1.15

Overview

Crescent Biopharma, Inc. (CBIO) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CBIO · as of Feb 26, 2026

Latest filing snapshot

+40+1000.00%vs prior year

Crescent Biopharma, Inc. (CBIO) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

+40

Growth % (1Y)

+1000.00%

Revenue / Employee

$246.5K

Net Income / Employee

$-3.50M

Market Cap

$476M

CBIO Employee Count

2013 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-26	2025-12-31	44	+40	+1000.00%
2025-02-13	2024-12-31	4	-31	-88.57%
2024-03-27	2023-12-31	35	-4	-10.26%
2023-03-29	2022-12-31	39	-13	-25.00%
2022-03-03	2021-12-31	52	-2	-3.70%
2021-03-02	2020-12-31	54	-3	-5.26%
2020-02-28	2019-12-31	57	+7	+14.00%
2019-03-06	2018-12-31	50	+10	+25.00%
2018-03-06	2017-12-31	40	-2	-4.76%
2017-03-01	2016-12-31	42	+4	+10.53%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

HRTX

Heron Therapeutics, Inc.

122$72M #2

CCCC

C4 Therapeutics, Inc.

Armata Pharmaceuticals, Inc.

60$278M #5

IMDX

Insight Molecular Diagnostics Inc.

46$154M #6

CBIO

Crescent Biopharma, Inc.YOU

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CBIO peer comparison

About CBIO employees

CBIO Employees · Headcount

Crescent Biopharma, Inc. (CBIO) employee data is sourced from the annual SEC 10-K filing. As of 2025, Crescent Biopharma, Inc. had 44 full-time employees globally. Full-time employees only. Global consolidated headcount.

Crescent Biopharma, Inc. employs 44 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $246,455, reflecting the company's operational efficiency.

Crescent Biopharma, Inc.'s workforce increased by 40 (1000.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Crescent Biopharma, Inc.'s revenue per employee of $246,455 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

CBIO Employees · 5 questions

As of the latest SEC 10-K filing (2025), Crescent Biopharma, Inc. had 44 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Crescent Biopharma, Inc. employee counthow many employees does Crescent Biopharma, Inc. haveCBIO total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-26